Overview

Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of RX-1741, an oxazolidinone, versus linezolid, another oxazolidinone, in the treatment of uncomplicated skin and skin structure infections
Phase:
Phase 2
Details
Lead Sponsor:
Melinta Therapeutics, Inc.
Treatments:
Linezolid
Oxazolidinones
Radezolid